Code of Federal Regulations (Last Updated: November 8, 2024) |
Title 10 - Energy |
Chapter I - Nuclear Regulatory Commission |
Part 35 - Medical Use of Byproduct Material |
Subpart C - General Technical Requirements |
§ 35.65 - Authorization for calibration, transmission, and reference sources.
-
§ 35.65 Authorization for calibration, transmission, and reference sources.
.(a) Any person authorized by § 35.11 for medical use of byproduct material may receive, possess, and use any of the following byproduct material for check, calibration, transmission, and reference use
b:
a(
.1) Sealed sources, not exceeding 1.11 GBq (30 mCi) each, manufactured and distributed by a person licensed under § 32.74 of this chapter or equivalent Agreement State regulations
;
(
.2) Sealed sources, not exceeding 1.11 GBq (30 mCi) each, redistributed by a licensee authorized to redistribute the sealed sources manufactured and distributed by a person licensed under § 32.74 of this chapter or equivalent Agreement State regulations, providing the redistributed sealed sources are in the original packaging and shielding and are accompanied by the manufacturer's approved instructions
c;
(
.3) Any byproduct material with a half-life not longer than 120 days in individual amounts not to exceed 0.56 GBq (15 mCi)
d;
(
µCi4) Any byproduct material with a half-life longer than 120 days in individual amounts not to exceed the smaller of 7.4 MBq (200
AppendixµCI) or 1000 times the quantities in
Part .appendix B of
e; or
(
[67 FR 20370, Apr. 24, 2002, as amended at 71 FR 15009, Mar. 27, 20065) Technetium-99m in amounts as needed.
(b) Byproduct material in sealed sources authorized by this provision shall not be:
(1) Used for medical use as defined in § 35.2 except in accordance with the requirements in § 35.500; or
(2) Combined (i.e., bundled or aggregated) to create an activity greater than the maximum activity of any single sealed source authorized under this section.
(c) A licensee using calibration, transmission, and reference sources in accordance with the requirements in paragraph (a) or (b) of this section need not list these sources on a specific medical use license.
[83 FR 33106, July 16, 2018]